14
Mar
2022
Structural Biology-Driven Drug Discovery: Ray Stevens on The Long Run
Today’s guest on the Long Run is Ray Stevens. Ray is the CEO of ShouTi. It’s a company that uses advanced structural biology technologies like cryo-EM images, and computational techniques, to discover small molecule drugs. The idea is to come up with orally available medicines that can build off the biological insights gained from protein or peptide drugs, but replace... Read More